Clinical Trial Update: First Line Therapy of Advanced Stage Follicular Lymphoma in Patients < 60 Years Not Eligible fo Standard Immunochemotherapy and in All Patients ≥ 60 Years [Phase 2]

View source ↗

Summary

Phase 2 trial update on first-line therapy for advanced Follicular Lymphoma in patients under 60 not eligible for standard immunochemotherapy and in all patient…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma
• Indolent Non-hodgkin Lymphoma

Snippet

Sponsor: Prof. Dr. Wolfgang Hiddemann | Conditions: Indolent Non-hodgkin Lymphoma | Phase 2 | Status: COMPLETED